feed,title,long_url,short_url
Benzinga,Pfizer's Lorlatinib Scores European Approval In ALK-Positive Lung Cancer,https://benzinga.com/general/biotech/22/01/25284867/pfizers-lorlatinib-scores-european-approval-in-alk-positive-lung-cancer,https://bit.ly/33XlRmN
Benzinga,FDA Approves Insulet's Omnipod Automated Insulin Delivery System Patients Aged 6 Years & Above,https://benzinga.com/trading-ideas/long-ideas/22/01/25283987/fda-approves-insulets-omnipod-automated-insulin-delivery-system-patients-aged-6-years-ab,https://bit.ly/3G7NpTt
Benzinga,Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting,https://benzinga.com/general/biotech/22/01/25283603/humacyte-posts-preclinical-data-of-small-diameter-human-acellular-vessel-in-bypass-grafting,https://bit.ly/3Hb0OM1
